135 related articles for article (PubMed ID: 11840344)
1. Corneal stimulation of MMP-1, -9 and uPA by platelet-activating factor is mediated by cyclooxygenase-2 metabolites.
Ottino P; Bazan HE
Curr Eye Res; 2001 Aug; 23(2):77-85. PubMed ID: 11840344
[TBL] [Abstract][Full Text] [Related]
2. Platelet-activating factor enhances urokinase-type plasminogen activator gene expression in corneal epithelium.
Tao Y; Bazan HE; Bazan NG
Invest Ophthalmol Vis Sci; 1996 Sep; 37(10):2037-46. PubMed ID: 8814143
[TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor induces the expression of metalloproteinases-1 and -9, but not -2 or -3, in the corneal epithelium.
Tao Y; Bazan HE; Bazan NG
Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):345-54. PubMed ID: 7843905
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor induces the gene expression of TIMP-1, -2, and PAI-1: imbalance between the gene expression of MMP-9 and TIMP-1 and -2.
Ottino P; Taheri F; Bazan HE
Exp Eye Res; 2002 Mar; 74(3):393-402. PubMed ID: 12014920
[TBL] [Abstract][Full Text] [Related]
5. Platelet-activating factor induces cyclooxygenase-2 gene expression in corneal epithelium. Requirement of calcium in the signal transduction pathway.
Bazan HE; Tao Y; DeCoster MA; Bazan NG
Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2492-501. PubMed ID: 9375567
[TBL] [Abstract][Full Text] [Related]
6. The effect of selective cyclooxygenase-2 inhibitor on corneal angiogenesis in the rat.
Yamada M; Kawai M; Kawai Y; Mashima Y
Curr Eye Res; 1999 Oct; 19(4):300-4. PubMed ID: 10520225
[TBL] [Abstract][Full Text] [Related]
7. PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts.
Ottino P; He J; Axelrad TW; Bazan HE
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):487-96. PubMed ID: 15671273
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases.
Attiga FA; Fernandez PM; Weeraratna AT; Manyak MJ; Patierno SR
Cancer Res; 2000 Aug; 60(16):4629-37. PubMed ID: 10969817
[TBL] [Abstract][Full Text] [Related]
9. Platelet activating factor increases ciliary activity in the hamster oviduct through epithelial production of prostaglandin E2.
Hermoso M; Barrera N; Morales B; Pérez S; Villalón M
Pflugers Arch; 2001 Jun; 442(3):336-45. PubMed ID: 11484763
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2-dependent prostaglandin (PG) E2 downregulates matrix metalloproteinase-3 production via EP2/EP4 subtypes of PGE2 receptors in human periodontal ligament cells stimulated with interleukin-1alpha.
Yan M; Noguchi K; Ruwanpura SM; Ishikawa I
J Periodontol; 2005 Jun; 76(6):929-35. PubMed ID: 15948687
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide (NO) modulation of PAF-induced cardiopulmonary action: interaction between NO synthase and cyclo-oxygenase-2 pathways.
Fabi F; Calabrese R; Stati T; del Basso P
Br J Pharmacol; 2001 Oct; 134(4):777-88. PubMed ID: 11606318
[TBL] [Abstract][Full Text] [Related]
12. Platelet-activating factor preferentially stimulates the phospholipase A2/cyclooxygenase cascade in the rabbit cornea.
Hurst JS; Bazan HE
Curr Eye Res; 1995 Sep; 14(9):769-75. PubMed ID: 8529415
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 mediates platelet-activating factor-induced prostaglandin E2 release from rat primary astrocytes.
Teather LA; Wurtman RJ
Neurosci Lett; 2003 Apr; 340(3):177-80. PubMed ID: 12672535
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer.
Yao M; Lam EC; Kelly CR; Zhou W; Wolfe MM
Br J Cancer; 2004 Feb; 90(3):712-9. PubMed ID: 14760389
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 level and culture conditions influence NS398-induced apoptosis and caspase activation in lung cancer cells.
Chang HC; Weng CF
Oncol Rep; 2001; 8(6):1321-5. PubMed ID: 11605058
[TBL] [Abstract][Full Text] [Related]
16. Effects of platelet activating factor, butyrate and interleukin-6 on cyclooxygenase-2 expression in human esophageal cancer cells.
Wang LS; Chow KC; Wu YC
Scand J Gastroenterol; 2002 Apr; 37(4):467-75. PubMed ID: 11989839
[TBL] [Abstract][Full Text] [Related]
17. PAF antagonists as possible inhibitors of corneal epithelial defects and ulceration.
Bazan HE; Tao Y
J Ocul Pharmacol Ther; 1997 Jun; 13(3):277-85. PubMed ID: 9185044
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 regulates prostaglandin E2 signaling in hippocampal long-term synaptic plasticity.
Chen C; Magee JC; Bazan NG
J Neurophysiol; 2002 Jun; 87(6):2851-7. PubMed ID: 12037188
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 is upregulated in inflamed gingival tissues.
Morton RS; Dongari-Bagtzoglou AI
J Periodontol; 2001 Apr; 72(4):461-9. PubMed ID: 11338298
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2-derived E prostaglandins down-regulate matrix metalloproteinase-1 expression in fibroblast-like synoviocytes via inhibition of extracellular signal-regulated kinase activation.
Pillinger MH; Rosenthal PB; Tolani SN; Apsel B; Dinsell V; Greenberg J; Chan ES; Gomez PF; Abramson SB
J Immunol; 2003 Dec; 171(11):6080-9. PubMed ID: 14634122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
